MetLife Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-12,682
| Closed | -$1.3M | – | 3031 |
|
|
2023
Q2 | $1.3M | Sell |
12,682
-115
| -0.9% | -$11.8K | 0.01% | 1129 |
|
|
2023
Q1 | $1.4M | Buy |
12,797
+30
| +0.2% | +$3.27K | 0.01% | 1059 |
|
|
2022
Q4 | $1.45M | Sell |
12,767
-514
| -4% | -$58.5K | 0.01% | 1026 |
|
|
2022
Q3 | $822K | Buy |
13,281
+1
| +0% | +$62 | 0.01% | 1291 |
|
|
2022
Q2 | $1.06M | Buy |
13,280
+7,091
| +115% | +$566K | 0.01% | 1176 |
|
|
2022
Q1 | $651K | Buy |
+6,189
| New | +$651K | ﹤0.01% | 1614 |
|
|
2019
Q3 | – | Sell |
-78,412
| Closed | -$1.89M | – | 2475 |
|
|
2019
Q2 | $1.89M | Hold |
78,412
| – | – | 0.02% | 843 |
|
|
2019
Q1 | $2.07M | Buy |
78,412
+4,806
| +7% | +$127K | 0.02% | 807 |
|
|
2018
Q4 | $1.44M | Hold |
73,606
| – | – | 0.02% | 897 |
|
|
2018
Q3 | $1.44M | Buy |
+73,606
| New | +$1.44M | 0.01% | 988 |
|